Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase III Study to Evaluate the Efficacy and Safety of Fruquitinib in Combination With Paclitaxel Versus Paclitaxel Alone in Second Line Gastric Cancer

Trial Profile

A Phase III Study to Evaluate the Efficacy and Safety of Fruquitinib in Combination With Paclitaxel Versus Paclitaxel Alone in Second Line Gastric Cancer

Status: Recruiting
Phase of Trial: Phase III

Latest Information Update: 28 Nov 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Fruquintinib (Primary) ; Paclitaxel (Primary)
  • Indications Adenocarcinoma; Gastric cancer; Oesophageal cancer
  • Focus Proof of concept; Registrational; Therapeutic Use
  • Acronyms FRUTIGA
  • Sponsors Hutchison MediPharma
  • Most Recent Events

    • 28 Nov 2019 According to a Chi-Med (Hutchison China MediTech Limited ) media release, in April 2019, the company conducted an interim analysis of this study for futility. The analysis evaluated PFS and OS trends after six months of therapy for the first 100 patients recruited into the study. The Independent Data Monitoring Committee (IDMC) recommended to continue the study without changes.
    • 28 Nov 2019 According to a Chi-Med (Hutchison China MediTech Limited ) media release, enrollment of this study is expected to be completed in mid-2020 with top line results in early 2021.
    • 15 Oct 2019 Planned primary completion date changed from 1 Aug 2019 to 1 Apr 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top